welcomes you to the new, improved website!This study reports ten year outcomes of the STICH trial. Comparing CABG to medical therapy groups, the authors note that CABG reduced all cause, cardiovascular, and heart failure hospitalizations. This included time-to-first and recurrent events. This was due to fewer total cardiovascular hospitalizations, the majority due to heart failure.
You are here:
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial
Source: JACC: Heart Failure
Keywords:
Author(s): Jonathan G. Howlett, Amanda Stebbins, Mark C. Petrie, Pardeep S. Jhund, Serenella Castelvecchio, Alexander Cherniavsky, Carla A. Sueta, Ambuj Roy, Ileana L. Piña, Raphael Wurm, Mark H. Drazner, Bert Andersson, Carmen Batlle, Michele Senni, Lukasz Chrzanowski, Bela Merkely, Peter Carson, Patrice M. Desvigne-Nickens, Kerry L. Lee, Eric J. Velazquez, Hussein R. Al-Khalidi on behalf of the STICH Trial Investigators
1 Comment
good